Business Description
ANG Lifesciences India Ltd
ISIN : INE236W01016
Total Employee Number:
412Compare
Compare
Traded in other countries / regions
540694.India IPO Date
2017-09-08Description
ANG Lifesciences India Ltd is engaged in the business of manufacturing and sales of finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials, liquid injection vials, ampoules, PFS, hard gelatin capsules, soft gelatin capsules, dry syrups, liquid syrups and suspension, lotions, etc. Its product portfolio comprises various therapeutic categories such as antibiotics, antivirals, antimalarial, antiulcer, carbapenem, corticosteroid, penicillin, beta-lactamase inhibitor, etc. Through its subsidiary, it is also involved in the business of printing and packing solutions. The group's reportable segments are Pharmaceuticals, which derive maximum revenue, and Packaging and printing. Geographically, it derives maximum revenue from India.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.1 | |||||
Equity-to-Asset | 0.25 | |||||
Debt-to-Equity | 1.5 | |||||
Debt-to-EBITDA | 63.48 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 0.54 | |||||
Beneish M-Score | -2.63 | |||||
WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -25 | |||||
3-Year EBITDA Growth Rate | -62.2 | |||||
3-Year EPS without NRI Growth Rate | -302.7 | |||||
3-Year FCF Growth Rate | -12.7 | |||||
3-Year Book Growth Rate | -15 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 53.52 | |||||
9-Day RSI | 51.22 | |||||
14-Day RSI | 52.63 | |||||
3-1 Month Momentum % | 28.14 | |||||
6-1 Month Momentum % | 23.5 | |||||
12-1 Month Momentum % | -2.05 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1 | |||||
Quick Ratio | 0.69 | |||||
Cash Ratio | 0.05 | |||||
Days Inventory | 303.41 | |||||
Days Sales Outstanding | 290.21 | |||||
Days Payable | 389.71 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -0.67 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 34.83 | |||||
Operating Margin % | -6.05 | |||||
Net Margin % | -11.93 | |||||
EBITDA Margin % | 1.35 | |||||
FCF Margin % | 11.4 | |||||
OCF Margin % | 11.87 | |||||
ROE % | -18.91 | |||||
ROA % | -4.88 | |||||
ROIC % | -3.1 | |||||
ROC (Joel Greenblatt) % | -3.98 | |||||
ROCE % | -6.98 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shiller PE Ratio | 7.13 | |||||
PS Ratio | 0.48 | |||||
PB Ratio | 0.85 | |||||
Price-to-Tangible-Book | 0.84 | |||||
Price-to-Free-Cash-Flow | 4.2 | |||||
Price-to-Operating-Cash-Flow | 4.01 | |||||
EV-to-EBIT | -22.81 | |||||
EV-to-EBITDA | 92.62 | |||||
EV-to-Revenue | 1.25 | |||||
EV-to-FCF | 10.89 | |||||
Price-to-GF-Value | 1.11 | |||||
Price-to-Projected-FCF | 1.09 | |||||
Earnings Yield (Greenblatt) % | -4.37 | |||||
FCF Yield % | 23.84 | |||||
Forward Rate of Return (Yacktman) % | 2.9 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ANG Lifesciences India Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 928.928 | ||
| EPS (TTM) (₹) | -8.472 | ||
| Beta | 1.4971 | ||
| 3-Year Sharpe Ratio | -0.11 | ||
| 3-Year Sortino Ratio | -0.19 | ||
| Volatility % | 93.09 | ||
| 14-Day RSI | 52.63 | ||
| 14-Day ATR (₹) | 2.698382 | ||
| 20-Day SMA (₹) | 34.758 | ||
| 12-1 Month Momentum % | -2.05 | ||
| 52-Week Range (₹) | 17.63 - 49.69 | ||
| Shares Outstanding (Mil) | 13.06 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ANG Lifesciences India Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ANG Lifesciences India Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| 1.25:1 Stock Split | 2022-07-13 | 188.28 (+0.15%) | ||
| 2:1 Stock Split | 2021-09-22 | 252.40 (+2.59%) |
Show
Entries
ANG Lifesciences India Ltd Frequently Asked Questions
What is ANG Lifesciences India Ltd(BOM:540694)'s stock price today?
The current price of BOM:540694 is ₹34.01. The 52 week high of BOM:540694 is ₹49.69 and 52 week low is ₹17.63.
When is next earnings date of ANG Lifesciences India Ltd(BOM:540694)?
The next earnings date of ANG Lifesciences India Ltd(BOM:540694) is .
Does ANG Lifesciences India Ltd(BOM:540694) pay dividends? If so, how much?
ANG Lifesciences India Ltd(BOM:540694) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on ANG Lifesciences India Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers